XTL Biopharmaceuticals Ltd. (FRA:H2K2)
Germany · Delayed Price · Currency is EUR 0.6450
-0.0050 (-0.77%)
At close: Nov 28, 2025
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of €7.44 million as of December 1, 2025. Its market cap has decreased by -56.47% in one year.
Market Cap
7.44M
Enterprise Value
6.47M
Revenue
435.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.65
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 144.96M to 7.44M, a decrease of -94.87%. That is a compound annual growth rate of -13.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 7.44M | -65.59% |
| Dec 31, 2024 | 21.62M | 351.29% |
| Dec 31, 2023 | 4.79M | -19.50% |
| Dec 29, 2022 | 5.95M | -55.04% |
| Dec 30, 2021 | 13.24M | 3.31% |
| Dec 31, 2020 | 12.81M | 105.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |